{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:16:59Z","timestamp":1762867019025,"version":"3.40.5"},"reference-count":5,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,8]],"date-time":"2016-12-08T00:00:00Z","timestamp":1481155200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","jfma-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jfma.2016.12.005","type":"journal-article","created":{"date-parts":[[2017,1,7]],"date-time":"2017-01-07T12:30:58Z","timestamp":1483792258000},"page":"407-409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Treatment of de novo hepatitis C virus-related fibrosing cholestatic hepatitis after orthotopic heart transplantation by ledipasvir and sofosbuvir"],"prefix":"10.1016","volume":"116","author":[{"given":"Chen-Hua","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yih-Sharng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheoi-Shen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2442-7952","authenticated-orcid":false,"given":"Jia-Horng","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2016.12.005_bib1","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1056\/NEJM199209243271302","article-title":"Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs","volume":"327","author":"Pereira","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2016.12.005_bib2","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1002\/hep.510300519","article-title":"Outcome of de novo hepatitis C virus infection in heart transplant recipients","volume":"30","author":"Ong","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2016.12.005_bib3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jfma.2015.06.012","article-title":"Hepatitis C virus infection in Taiwan: past, present, and future","volume":"115","author":"Kao","year":"2016","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2016.12.005_bib4","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jfma.2014.09.001","article-title":"Emerging treatments for chronic hepatitis C","volume":"114","author":"Hayes","year":"2015","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2016.12.005_bib5","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jhep.2015.09.002","article-title":"Pros and cons: usage of organs from donors infected with hepatitis C virus\u2014revision in the direct-acting antiviral era","volume":"64","author":"Coilly","year":"2016","journal-title":"J Hepatol"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092966461630451X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092966461630451X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T03:26:53Z","timestamp":1536118013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092966461630451X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S092966461630451X"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2016.12.005","relation":{},"ISSN":["0929-6646"],"issn-type":[{"type":"print","value":"0929-6646"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of de novo hepatitis C virus-related fibrosing cholestatic hepatitis after orthotopic heart transplantation by ledipasvir and sofosbuvir","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2016.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017, Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}